‘D Yellow Elephant’ , a full service digital agency with a focus on pharmaceutical and healthcare industry initiated its India operations.
Led by a team with extensive experience in the Pharmaceuticals and Healthcare industry, ‘D Yellow Elephant’s’ mission is to create meaningful and measurable interactive web marketing for the world’s largest health & pharma brands and corporates.
The new firm counts 3 offices and approximately 20 staffers across the globe with operations in the United States, Europe and Asia.
The creation of D Yellow Elephant was spurred by the desire of the Aman Gupta, Co-Founder and one of the most respected names in pharmaceutical marketing, to build a truly global and integrated digital firm focused on delivering groundbreaking work in the Pharmaceuticals and Healthcare sector.
“D Yellow Elephant is an interaction firm, not a communication firm,” Said Aman Gupta.
He further added, “We have been the experts in Healthcare communications for more than 2 decades now and while digital communications have always been a part of overall structure, a need was felt to leverage our best capabilities through a medium which is bound to bring change in the coming future. D Yellow Elephant was created to respond to the need of specialized firm catering to Pharmaceuticals sector and fill in the gap with expert led, digitally oriented marketing ideas. With D Yellow Elephant, we can address not just advertising, but all points where consumers and brands come together, no matter what the channel or platform”
The firm spent a full year aligning the global services structure, company cultures and delivery model.
D Yellow Elephant develops solutions across a full range of digital media including mobile, web, television, out-of home, tablet, touch, online advertising and social media, bringing together technology and creativity in new ways that drive business growth and consumer interest.
- D Yellow Elephant fulfils the need for specialised digital firm focused on the Pharmaceuticals and Healthcare sector.
- Formed by a team armed with 2 decades of pharmaceutical experience, a team that understands the sensitivity of the industry
Patients are increasingly harnessing the Internet to gain knowledge about health conditions and even self-diagnose, leading to a more empowered health consumer and more informed patient-physician conversations, in this new age of participatory medicine, pharmaceutical companies must start by understanding what health communities want and then use digital technologies to reach them with information that meets the demand and takes into account applicable regulations in their markets